Oncologists weigh second-line options after IO/TKI failure in metastatic ccRCC, highlighting tolerability, mechanism shifts, and belzutifan’s broader role.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science.

Rules being drafted by the Treasury Department would likely allow American drugmakers to invest in promising medicines being ...

The other is that Anthropic will prioritise the interests of a subset of countries, defined either as the US and allies, or democracies, which have, respectively, only 17 per cent and 45 per cent of ...

Have you ever heard of 'blockbuster drugs'? They're called that for a reason. Because they generate US$1bn or more in annual ...

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if ...

A Brief History of Lyell Immunopharma◾️Lyell Immunopharma, founded by cell therapy expertsFounders and BackgroundLyell Immunopharma is a clinical-stage biopharmaceutical company founded in 2018 by ...

All deal values reflect company disclosures. Where parties have not disclosed terms, they are reported as undisclosed. No ...

Sir Keir Starmer’s decision to invite Sir Pascal Soriot, AstraZeneca’s chief executive, to Beijing at the beginning of the year was a textbook piece of modern diplomacy.

Bristol-Myers Squibb (NYSE: BMY) declared a quarterly dividend of $0.63 per share, or $2.52 annualized.The dividend will be payable on November 2, 2026, to stockholders of record on October 2, 2026, ...

New evidence shows GLP-1s are safe and potentially life-extending for patients with complex psychiatric histories. Here is how to translate the research into clear, effective conversations.